Caricamento...
Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?
Programmed death 1 (PD-1, CD279) and programmed death ligand 1 (PD-L1, CD274) are involved in generating tumor-associated immunosuppression by suppression of T-cell proliferation and interleukin 2 (IL-2) production and immune checkpoint inhibitors targeting these molecules are showing compelling act...
Salvato in:
| Pubblicato in: | Clin Neuropathol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dustri-Verlag Dr. Karl Feistle
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4766797/ https://ncbi.nlm.nih.gov/pubmed/26501438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/NP300922 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|